Effect of psychotherapy for depression via home telehealth on glycemic control in adults with type 2 diabetes: Subgroup analysis of a randomized clinical trial

Abstract

Objective

We evaluated the impact of telemedicine-delivered behaviour activation treatment (BAT) on glycemic control in a subgroup of older adults with diabetes who participated in a randomized controlled trial for depression.

Research design and methods

We randomized older adults with major depression to same-room or telemedicine BAT. Each group received eight weekly sessions. For the subgroup analysis, we identified individuals with type 2 diabetes and obtained hemoglobin A1c at baseline and 12 months’ follow-up. We used mixed-effects models (MEM) for repeated measures analysis to compare the longitudinal mean A1c. We estimated model-derived mean A1c values and considered an adjusted model to account for baseline health status.

Results

We included 90 individuals with type 2 diabetes of the original 241 in the subgroup analysis (43 in telemedicine and 47 in same room). Treatment groups were not significantly different at baseline for demographics, depression, anxiety or A1c levels (telemedicine 6.9 vs. same room 7.3, p = 0.19). Baseline mean A1c for the telemedicine group remained at 6.9 (55 mmol/mol) at 12 months, whereas baseline mean A1c for the same-room group increased to 7.7 (61 mmol/mol). Longitudinal trajectories of model-derived mean A1c indicated a significant main effect of treatment group on mean A1c value at study end (difference = −0.82, 95% CI −1.41, −0.24). Adjusted analyses gave comparable results.

Conclusions

Telemedicine-delivered BAT was superior to same room in achieving lower mean A1c values in participants with type 2 diabetes, suggesting BAT-delivered via telemedicine is a viable treatment option for adults with diabetes.

Keywords

Telehealth telepsychology home telecare

Get full access to this article

View all access options for this article.

References

Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2014. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2014.

Egede

Ellis

. Diabetes and depression: Global perspectives. Diabetes Res Clin Pract 2010; 87: 302–312.

Anderson

Freedland

Clouse

et al.

The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001; 24: 1069–1078.

Ford

Zhao

et al.

Prevalence and correlates of undiagnosed depression among US adults with diabetes: The Behavioral Risk Factor Surveillance System. Diabetes Res Clin Pract 2009; 83: 268–279.

Ali

Stone

Skinner

et al.

The association between depression and health-related quality of life in people with type 2 diabetes: A systematic literature review. Diabetes Metab Res Rev 2010; 26: 75–89.

Dismuke

Egede

. Association between major depression, depressive symptoms and personal income in US adults with diabetes. Gen Hosp Psychiatry 2010; 32: 484–491.

Egede

Zheng

Simpson

. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25: 464–470.

Ciechanowski

Katon

Russo

. Depression and diabetes: Impact of depressive symptoms of adherence, function, and costs. Arch Intern Med 2000; 160: 3278–3285.

Egede

Bishu

Walker

et al.

Impact of diagnosed depression on heathcare costs in adults with and without diabetes: United States, 2004–2011. J Affect Disord 2016; 195: 119–126.

10.

Nichols

Barton

Glazner

et al.

Diabetes, minor depression and health care utilization and expenditure: A retrospective database study. Cost Eff Resourc Alloc 2007; 5: 4–4.

11.

Unützer

Schoenbaum

Katon

et al.

Healthcare costs associated with depression in medically ill fee-for-service Medicare participants. J Am Geriatr Soc 2009; 57: 506–510.

12.

Greenberg

Fournier

Sisisky

et al.

The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 2015; 76: 155–162.

13.

Alexopoulos

. Depression in the elderly. Lancet 2005; 365: 1961–1970.

14.

Centers for Disease Control and Prevention (CDC). Current depression among adults—United States. 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1229–1235.

15.

Egede

Walker

Bishu

et al.

Trends in costs of depression in adults with diabetes in the United States: Medical Expenditure Panel Survey, 2004–2011. J Gen Intern Med 2016; 31: 615–622.

16.

Snowden

Steinman

Frederik

. Treating depression in older adults: Challenges to implementing the recommendations of an expert panel. Prev Chronic Dis 2003; 5: A26–A26.

17.

Ivanova

Bienfait-Beuzon

Birnbaum

et al.

Physicians’ decisions to prescribe antidepressant therapy in older patients with depression in a US managed care plan. Drugs Aging 2011; 28: 51–62.

18.

Stojanović-Špehar

Ozretić

Blažeković-Milaković

et al.

Late life depression: Challenge or curse for the general practitioner (GP). A cohort study. Arch Genontol Geriatr 2011; 52: 134–139.

19.

Lejuez

Hopko

. A brief behavioral activation treatment for depression. Treatment manual. Behav Modif 2001; 25: 255–286.

20.

Lejuez

Hopko

Acierno

et al.

Ten-year revision of the brief behavioral activation treatment for depression: Revised treatment manual. Behav Modif 2011; 35: 111–161.

21.

Katon

Unützer

Fan

et al.

Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006; 29: 265–270.

22.

Katon

Russo

Von Korff

et al.

Long-term effects on medical cost of improving depression outcomes in patients with depression and diabetes. Diabetes Care 2008; 31: 1155–1159.

23.

Eli

Katon

Xie

et al.

One-year postcollaborative depression care trial outcomes among predominantly Hispanic diabetes safety net patients. Gen Hosp Psychiatry 2011; 33: 436–442.

24.

Eli

Katon

Lee

et al.

Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net care. Psychosomatics 2012; 53: 347–355.

25.

Schneider

Panza

Handschin

et al.

Feasibility of pairing behavioral activation with exercise for women with type 2 diabetes and depression: The Get It Study pilot randomized controlled trial. Behav Ther 2016; 47: 198–212.

26.

Kaltman

Serrano

Talisman

et al.

Type 2 diabetes and depression: A pilot trial of an integrated self-management intervention for Latino immigrants. Diabetes Educ 2016; 42: 87–95.

27.

Egede

Acierno

Knapp

et al.

Psychotherapy for depression in older veterans via telemedicine: A randomized, open-label, non-inferiority trial. Lancet Psychiatry 2015; 2: 693–701.

28.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision (DSM-IV-TR) , Washington, DC: American Psychiatric Association, 2000.

29.

Egede

Frueh

Richardson

et al.

Rationale and design: Telepsychology service delivery for depressed elderly veterans. Trials 2009; 10: 22–22.

30.

Hunt

Gebregziabher

Lynch

et al.

Impact of diabetes control on mortality by race in a national cohort of veterans. Ann Epidemiol 2013; 23: 74–79.

31.

Egede

Mueller

Echols

et al.

Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Med Care 2010; 48: 527–533.

32.

Selvin

Marinopoulos

Berkenblit

et al.

Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421–431.

33.

Shalev

Chodick

Bialik

et al.

In a population-based cohort of diabetes patients, men and women had similar risks for all-cause mortality. J Clin Epidemiol 2007; 60: 86–93.

34.

Wong

Wang

Liu

et al.

Do Veterans Health Administration enrollees generalize to other populations?

Med Care Res Rev 2016; 73: 493–507.